Member Info for x54v

Plenty of cash...

"This cash sees us all the way through into 2021 as we set out at the fundraise last year. So other partner programs are fully funded by the partners so we have more than 12 months cash runway now as we set out last year."

https://tinyurl.com/tzdw3gv

https://avacta.com/wp-content/uploads/2020/01/finnCap-Avacta-trading-update-23.01.20.pdf

"We maintain our target price of 76p."

https://www.finncap.com/news-events/finncap-research-company-notes-23-january-2020

Massive upside from the current price.

Strong update today. Overhang clearing rapidly and providing a great opportunity to get in on the cheap.

Friel putting in £500k at 6.6p by the looks of it...

"We're looking to raise money at about 6.6. I'm putting in up to half a million at that so we can ensure it's at that price."

https://tinyurl.com/yx82prc3

"But the excitement is only now starting – the company is now saying that a £5 million placing at 6.6p looks set to be heavily oversubscribed."

https://tinyurl.com/yx8yjcw5

Institutions all loading up heavily recently.

Lombard Odier up to 10.29%.
Oryx up to 9.33%
CIP Merchant taken a 3.41% position.
Richard Griffiths on 28.61%.

They know where this is going. A case of follow the money if ever there was one.

The volume is huge. Highest its been since late 2018. And it's not even 11am yet.

Hopefully the start of a new sustained move upwards.

Loads of buying this morning. And heavy volume too.

Something brewing?

The volume has really ramped up the last few days. Acquisition in the offing in the near future got to be a possibility.

Invesco may just be trimming. No way of telling.

The good news is that other instis have been keen buyers in recent weeks and have accumulated significant stakes. So quite possible that any shares currently being sold by Invesco are being bought up by the likes of Richard Griffiths, Oryx and Lombard Odier.

Shield Therapeutics (STX) an interesting parallel perhaps with regards institutional antics.

Right at the lows back in May 2018, and JP Morgan offload their stake around the 20p level down from 5.37% to unnotifiable:

https://investegate.co.uk/shield-therapeutics--stx-/rns/holding-s--in-company/201805040920351547N/

Nov 2018 and the shrewd Richard Griffiths takes his stake from unnotifiable to 7.79% around the 30p level:

https://investegate.co.uk/shield-therapeutics--stx-/rns/holding-s--in-company/201811081821098434G/

The price shortly thereafter rises strongly with Richard Griffiths trimming along the way but still holding nearly 5% at the current 185p (6x his purchase price):

https://investegate.co.uk/shield-therapeutics--stx-/rns/holding-s--in-company/201911291531372099V/

Yes, it'll be interesting to see who's been buying.

Large amounts so not likely to be PIs. So could well be any of Richard Griffiths, Oryx or Lombard Odier adding.

They've all shown themselves to be keen buyers building up significant stakes in recent weeks, so may have welcomed the opportunity to add in size at the current levels rather than having to chase the price.

The greater the % of the free float in sticky hands, the better the opportunity for a sustained rise over time.

Short term volatility providing an opportunity if you're thinking longer term as the bigger players currently are.

Plenty recent heavy loading up by instis shows confidence in the future:

. Richard Griffiths - 27.9%
. Oryx International - 7.99%
. Lombard Odier - 5.08%

Not forgetting the £100k director buy at 21p.

They'll all have done their due diligence and know where the price is going in time.

Richard Griffiths taking nearly 28% is particularly interesting. That's a significant chunk.

The short term volatility is just noise.

Maurice Treacy sounding bullish on today's podcast

https://audioboom.com/posts/7433540-nuformix-open-orphan-zoetic-international-and-live-company-group

https://audioboom.com/posts/7431911-valuethemarkets-podcast-032-with-maurice-treacy-chief-commercial-officer-of-open-orphan-orph

From 8 minutes onwards, sounds like news on genomic health database and more excitingly a bolt-on acquisition can be expected shortly.

There is a print at 12:52:10 today for 2.5m @ 0.716 on my feed. That was above mid at the time so it looks to be a buy.

"Get the feeling a number of resource juniors are about to materially breakout 🤔👍" https://twitter.com/pauljohnson9691/status/959045218036338688

"#THR continued 'larger' buys outweighing smaller sells all this week & 4p drawing in as the new baseline KAPUNDA Copper = 45,000 tonnes (potential) Resource Update imminent Estimated $317.4m = (45,000 x 2204 x $3.20 / lb) This project nearing commercialisation" https://twitter.com/andrew_neal7/status/959050829717278722

CB sounded very upbeat on this recent podcast: "Don't need every project to win. Any one of them is big enough and good enough to in actual fact give considerable shareholder uptick". "Should have very good newsflow over the next 6 months". https://audioboom.com/posts/6602701-galileo-resources-glr-toople-toop-african-battery-metals-abm-and-john-meyer-on-kod-geo If that's any guide then plenty of possible catalysts to drive the price very much higher in the coming year.

"Nice uplift in the Molybdenum price recently. Molyhil reserve includes 4,300 tonnes Mo @ US$27,200/tonne. A nice supplement to 10,200 tonnes WO3 @ US$31,500/tonne." https://twitter.com/MickBilling/status/956844698496204800